Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validating the Effect of Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum: A Double-Blind Randomised Placebo-Controlled Multicentre Trial

NCT03785691 is registered in ClinicalTrials.gov with Nordsjaellands Hospital as lead sponsor.

NCT NCT03785691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03785691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validating the Effect of Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum: A Double-Blind Randomised Placebo-Controlled Multicentre Trial
Lead sponsor
Nordsjaellands Hospital
Phase
Phase 2
Overall status
Terminated
Start date
March 1, 2019
Completion date
July 31, 2022
Enrollment
58 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hyperemesis gravidarum, nausea gravidarum, vomiting of pregnancy